EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants

Danyi Ao iD, Xuemei He, Weiqi Hong iD, Xiawei Wei iD

MedComm · 2023-04 · 4 (2)

DOI: 10.1002/mco2.239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm, online erschienen am 15.03.2023. Verfasst von Danyi Ao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geri…. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the fifth variant of concern of the SARS‐CoV‐2 virus, the Omicron variant (B.1.1.529) has quickly become the dominant type among the previous circulating variants worldwide. During the Omicron wave, several subvariants have emerged, with some exhibiting greater infectivity and immune evasion, accounting for their fast spread across many countries. Recently, two Omicron subvariants, BQ.1 and XBB lineages, including BQ.1.1, XBB.1, and XBB.1.5, have become a global public health issue given their ability to escape from therapeutic monoclonal antibodies and herd immunity induced by prior coronavirus disease 2019 (COVID‐19) vaccines, boosters, and infection. In this respect, XBB.1.5, which has been established to harbor a rare mutation F486P, demonstrates superior transmissibility and immune escape ability compared to other subvariants and has emerged as the dominant strain in several countries. This review provides a comprehensive overview of the epidemiological features, spike mutations, and immune evasion of BQ.1 and XBB lineages. We expounded on the mechanisms underlying mutations and immune escape from neutralizing antibodies from vaccinated or convalescent COVID‐19 individuals and therapeutic monoclonal antibodies (mAbs) and proposed strategies for prevention against BQ.1 and XBB sublineages.

Schlagwörter

Stichwörter der Autor:innen

BQ.1 and XBB lineagesOmicronXBB.1.5immune escape

Autor:innen und Institutionen

  • Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu Sichuan China.

ORCID-Profile: Danyi Ao, Weiqi Hong, Xiawei Wei

Zitieren

APA

Ao, D., He, X., Hong, W., & Wei, X. (2023). The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants. MedComm, 4(2). https://doi.org/10.1002/mco2.239

Vancouver

Ao D, He X, Hong W, Wei X. The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants. MedComm. 2023;4(2). doi:10.1002/mco2.239

BibTeX
@article{Ao2023,
  author = {Ao, Danyi and He, Xuemei and Hong, Weiqi and Wei, Xiawei},
  title = {The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants},
  journal = {MedComm},
  year = {2023},
  volume = {4},
  number = {2},
  doi = {10.1002/mco2.239}
}
Kostenlos starten →